813 results on '"Pernow, John"'
Search Results
202. Assessment of left ventricular structure and function in preeclampsia by echocardiography and cardiovascular biomarkers
203. Endothelial dysfunction induced by triglycerides is not restored by exenatide in rat conduit arteries ex vivo
204. Letter by Settergren et al Regarding Article, “Evidence for Statin Pleiotropy in Humans: Differential Effects of Statins and Ezetimibe on Rho-Associated Coiled-Coil Containing Protein Kinase Activity, Endothelial Function, and Inflammation”
205. PPAR-α activation protects the type 2 diabetic myocardium against ischemia-reperfusion injury: involvement of the PI3-Kinase/Akt and NO pathway
206. No effect of lipid lowering on platelet activity in patients with coronary artery disease and type 2 diabetes or impaired glucose tolerance
207. Intracoronary endothelin receptor blockade improves endothelial function in patients with coronary artery disease
208. Endothelial Function and Inflammatory Activity in Patients with Recent Onset of Severe Plaque Psoriasis
209. Small skin burn injury reduces cardiac tolerance to ischemia via a tumor necrosis factor alpha-dependent pathway
210. Cardioprotective effect of rosuvastatin in vivo is dependent on inhibition of geranylgeranyl pyrophosphate and altered RhoA membrane translocation
211. Vitamin C blocks vascular dysfunction and release of interleukin-6 induced by endothelin-1 in humans in vivo
212. Human Cytomegalovirus Up-Regulates Endothelin Receptor Type B: Implication for Vasculopathies?
213. Enhanced Endothelium-dependent Vasodilatation by Dual Endothelin Receptor Blockade in Individuals With Insulin Resistance
214. The endothelin-1 receptor antagonist bosentan protects against ischaemia/reperfusion-induced endothelial dysfunction in humans
215. Glucagon-like peptide-1 relaxes rat conduit arteries via an endothelium-independent mechanism
216. Nitric oxide mediates protective effect of endothelin receptor antagonism during myocardial ischemia and reperfusion
217. L-Arginine protects from ischemia-reperfusion-induced endothelial dysfunction in humans in vivo
218. Relation of hypertriglyceridemia to plasma concentrations of biochemical markers of inflammation and endothelial activation (C-reactive protein, interleukin-6, soluble adhesion molecules, von Willebrand factor, and endothelin-1)
219. ETA receptors mediate vasoconstriction, whereas ETB receptors clear endothelin-1 in the splanchnic and renal circulation of healthy men
220. ETA receptors mediate vasoconstriction, whereas ETB receptors clear endothelin-1 in the splanchnic and renal circulation of healthy men
221. Abstract 12529: Left Ventricular Gene Expression Heterogeneity in a Mouse Model of Dyssynchronous and Resynchronized Heart Failure
222. Abstract 12760: Microvascular Endothelial Dysfunction in Postural Orthostatic Tachycardia Syndrome Associated With Post-Acute Sequelae of COVID-19
223. Cardioprotective effect induced by brief exposure to nitric oxide before myocardial ischemia–reperfusion in vivo
224. Cardiovascular effects and cardiopulmonary plasma gradients following intravenous infusion of neuropeptide Y in humans: negative dromotropic effect on atrioventricular node conduction
225. Calcium Antagonist Clevidipine Reduces Myocardial Reperfusion Injury by a Mechanism Related to Bradykinin and Nitric Oxide
226. Combined Endothelin Receptor Blockade Evokes Enhanced Vasodilatation in Patients With Atherosclerosis
227. Endothelin-1 inhibits endothelium-dependent vasodilatation in the human forearm: reversal by ETA receptor blockade in patients with atherosclerosis
228. Endothelin-1 inhibits endothelium-dependent vasodilatation in the human forearm: reversal by ETA receptor blockade in patients with atherosclerosis
229. Urotensin II evokes potent vasoconstriction in humans in vivo
230. Endothelial dysfunction in atherosclerotic mice: improved relaxation by combined supplementation with L -arginine-tetrahydrobiopterin and enhanced vasoconstriction by endothelin
231. Cardioprotection from Ischemia and Reperfusion Injury by an Endothelin A-Receptor Antagonist in Relation to Nitric Oxide Production
232. Postexercise Ischemia Is Associated With Increased Neuropeptide Y in Patients With Coronary Artery Disease
233. Enhanced Vasoconstrictor Response to Endothelin-B-Receptor Stimulation in Patients with Atherosclerosis
234. Increased arginase levels contribute to impaired perfusion after cardiopulmonary resuscitation.
235. The Role of Arginase and Rho Kinase in Cardioprotection from Remote Ischemic Perconditioning in Non-Diabetic and Diabetic Rat In Vivo.
236. Human cytomegalovirus induces upregulation of arginase II: possible implications for vasculopathies.
237. Increased levels of circulating arginase I in overweight compared to normal weight adolescents.
238. Enhanced phenylephrine-induced rhythmic activity in the atherosclerotic mouse aorta via an increase in opening of KCa channels: relation to Kv channels and nitric oxide
239. Myocardial infarction mediated by endothelin receptor signaling in hypercholesterolemic mice
240. L-Arginine Enhances Functional Recovery and Ca2+-Dependent Nitric Oxide Synthase Activity After Ischemia and Reperfusion in the Rat Heart
241. Comparable Potent Coronary Constrictor Effects of Endothelin-1 and Big Endothelin-1 in Humans
242. Prejunctional regulation of reserpine-resistant sympathetic vasoconstriction and release of neuropeptide Y in the pig
243. Myocardial Release of Endothelin (ET) and Enhanced ETA Receptor-Mediated Coronary Vasoconstriction After Coronary Thrombosis and Thrombolysis in Pigs
244. Beneficial effects of the endothelin receptor antagonist bosentan on myocardial and endothelial injury following ischaemia/reperfusion in the rat
245. 907-101 Reduced Infarct Size and Improved Myocardial Blood Flow Following Ischemia and Reperfusion by a Non-peptide Endothelin Receptor Antagonist
246. The Nonpeptide Endothelin Receptor Antagonist Bosentan Enhances Myocardial Recovery and Endothelial Function During Reperfusion of the Ischemic Rat Heart
247. Local overflow and enhanced tissue content of endothelin following myocardial ischaemia and reperfusion in the pig: modulation by L-arginine
248. Repeated renal and splenic sympathetic nerve stimulation in anaesthetized pigs: maintained overflow of neuropeptide Y in controls but not after reserpine
249. Arginase regulates red blood cell nitric oxide synthase and export of cardioprotective nitric oxide bioactivity.
250. Endothelial regulation of coronary vascular tone in vitro: contribution of endothelin receptor subtypes and nitric oxide
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.